Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Client Alerts 36 results

Client Alert | 7 min read | 11.04.26

FDA Issues Guidance on Prescription Drug Use-Related Software

The U.S. Food & Drug Administration (FDA) recently issued final guidance — Regulatory Considerations for Prescription Drug Use-Related Software (PDURS) — to address when and how software disseminated by (or on behalf of) sponsors fits into existing drug-labeling requirements. The agency describes this as a response to longstanding uncertainty and a push toward a clearer, more consistent approach across FDA’s drug and device centers. 
...

Client Alert | 6 min read | 10.26.26

Executive Order Creates Women’s Health Task Force, Rescinds Prior Initiatives

On October 19, 2026, President Trump signed an executive order (EO) titled “Advancing Women’s Health to Improve Outcomes in All Phases of Life,” establishing new federal infrastructure dedicated to improving women’s health research, clinical translation, and coordinated policy leadership. The EO creates a White House Women’s Health Task Force and directs the U.S. Department of Health and Human Services (HHS) to establish a new Women’s Health Division within the National Institutes of Health (NIH).  
...

Client Alert | 6 min read | 10.16.26

Proposed AI Governance Framework: Risk-Mitigation Recommendations for Health Plans

Senator Maria Cantwell (D-Wash), the ranking member of the Senate Committee on Commerce, Science, and Transportation, recently outlined a comprehensive artificial intelligence (AI) governance framework designed to drive legislative and executive actions. The framework is built on six principles and is being introduced at a time when federal AI legislation is actively being debated. While the framework is a proposal, it reflects priorities that have bipartisan resonance and signals where lawmakers are likely to focus. For health insurance payors, several elements of the framework are directly relevant to existing and planned AI deployments, particularly in utilization management, claims processing, and member-facing services.
...

Client Alert | 4 min read | 10.14.26

Misleading Privacy Claims Can Trigger Massive Consumer-Protection Liability

At a glance: A New Mexico jury found Meta liable for nearly 44 million deceptive trade practice violations based on misleading privacy and platform-safety statements—showing that public-facing privacy claims can create significant consumer-protection exposure.
...

Client Alert | 4 min read | 10.08.26

California Governor Signs SB 690, Limiting Private Right of Action Under CIPA’s “Pen Register” and “Trap and Trace” Provisions

At a glance: Governor Gavin Newsom signed SB 690, amending CIPA to restrict private plaintiffs from bringing “pen register” and “trap and trace” claims arising from web-based conduct. The amendment is meant to reduce the wave of private CIPA litigation targeting website tracking technology. However, businesses remain exposed to several major types of claims and enforcement mechanisms under CIPA and related statutes and should audit their tracking technologies, consent mechanisms, and litigation posture accordingly.
...

Client Alert | 7 min read | 10.01.26

SEC and FDA Formalize Information-Sharing Framework for Public Companies

On August 31, 2026, the U.S. Securities and Exchange Commission (SEC) and the U.S. Food and Drug Administration (FDA) signed a Memorandum of Understanding (MOU) establishing a formal framework for the two agencies to share non-public information concerning FDA-regulated products and the companies and individuals engaged in their manufacture, distribution, and sale. The MOU was signed by SEC Chairman Paul S. Atkins and Acting FDA Commissioner Kyle Diamantas. It takes immediate effect and runs for three years, subject to renewal, modification, or termination. In a press release, Chairman Atkins described FDA-related disclosures by public companies as having “a significant impact on our markets” and identified the FDA as “a valuable partner in our efforts to administer and enforce applicable disclosure requirements under the federal securities laws.” Acting Commissioner Diamantas framed the MOU as protecting “both the patients who rely on FDA-regulated products, and the public trust that drives health care innovation.”
...

Client Alert | 7 min read | 09.22.26

ORI's Guidance on AI Misconduct: Disclose, Verify, and Preserve, or Face Consequences 

The U.S. Department of Health and Human Services’ (HHS) Office of Research Integrity (ORI) published its long-anticipated Guidance on Generative Artificial Intelligence in August. The guidance explains how generative AI (GenAI) use is evaluated under the revised research misconduct regulations (42 CFR Part 93), which took effect January 1, 2025, and became applicable to new allegations on January 1, 2026. The new guidance builds on prior guidance documents regarding the definitions of fabrication, falsification, and plagiarism, as well as revised evidentiary standards. As of April 30, 2026, institutions were required to have compliant policies on file with ORI as part of their annual report covering 2025. 
...

Client Alert | 6 min read | 09.03.26

FDA Seeks Input for Regulating GenAI-Powered Medical Devices

The U.S. Food & Drug Administration (FDA) is seeking feedback on a regulatory framework that could be used to evaluate generative artificial intelligence (GenAI)-enabled medical devices. Such devices could create new types of risks because their outputs can vary and evolve, unlike more traditional software-enabled devices. An August 18, 2026, discussion paper (“Considerations for the regulation of GenAI-enabled medical devices”) discusses potential regulatory considerations for GenAI-enabled medical devices. 
...

Client Alert | 7 min read | 08.17.26

Delayed Notification of Cyberattacks May Trigger HIPAA Breach Notification Rule

After identifying a ransomware attack in 2021, OSF Healthcare System waited until its forensic investigation had concluded before notifying the U.S. Department of Health and Human Services (HHS) — and the affected individuals — of the breach. The 110-day delay (nearly double the 60-calendar-day notification deadline mandated by the HIPAA Breach Notification Rule) triggered an investigation from HHS’s Office for Civil Rights (OCR). The health system’s investigation determined that protected health information (PHI) had been stolen.
...

Client Alert | 4 min read | 07.06.26

House Advances Bipartisan Kids' Online Safety Bill, But Senate Showdown Looms

On June 22, 2026, House Energy and Commerce Committee Chairman Brett Guthrie (R-Ky.) and Ranking Member Frank Pallone (D-N.J.) announced a bipartisan agreement on a revised version of the KIDS Act (H.R. 7757), marking the most significant congressional advance on children's online safety legislation in years. The House passed H.R. 7757, as amended, on June 29, 2026, setting up a potential showdown with the Senate. The revised KIDS Act consolidates elements of 14 pending legislative proposals — including KOSA and COPPA 2.0, both of which have previously passed the Senate and cleared the House Energy and Commerce Committee — into a single, comprehensive framework. The announcement, however, was met immediately with objections from Senate sponsors and civil liberties groups, underscoring the difficult legislative road ahead.
...

Client Alert | 7 min read | 05.27.26

Colorado Hits Reset on AI Regulation: SB 26-189 Repeals and Reenacts the Colorado AI Act

Colorado’s original AI Act (SB 24-205), signed in May 2024, imposed broad obligations on developers and deployers of “high-risk AI systems” — including requiring risk management programs, impact assessments, and affirmative steps to prevent algorithmic discrimination across employment, housing, lending, insurance, health care, and education decisions. The operative date for SB 24-205 was extended twice, and a court temporarily suspended enforcement in early 2026, following a lawsuit filed by xAI, which the U.S. Department of Justice (DOJ) intervened to support. Industry feedback on SB 24-205 was generally negative. In response to this environment, Colorado’s legislature undertook a rewrite, drafting and passing SB 26-189 in a matter of weeks. SB 26-189 reflects the legislature’s effort to preserve the policy goal of filling the AI oversight vacuum given the lack of a comprehensive federal law, but within a more workable compliance framework.
...

Client Alert | 5 min read | 05.12.26

NYDFS Ramps Up Health Care Cybersecurity Enforcement With $2.25 Million Settlement

On April 29, 2026, the New York Department of Financial Services (NYDFS) announced the finalization of a $2.25 million settlement with Delta Dental of New York and Delta Dental Insurance Co., resolving allegations that the affiliated companies failed to comply with the state’s stringent cybersecurity, consumer data protection, and incident reporting requirements. For health insurers, managed care organizations, and their third-party service providers operating in New York, the announcement comes as the latest signal that the NYDFS intends to aggressively enforce its cybersecurity regulations — which are widely considered the strictest in the nation following a 2023 overhaul. These regulations, codified at 23 NYCkRR 500 (Cybersecurity Requirements for Financial Services Organizations), apply to any entity licensed under New York insurance law, including health insurers, managed care organizations, and their third-party service providers.
...

Client Alert | 6 min read | 05.11.26

FDA’s AI in Early Phase Clinical Trials RFI: An Opportunity to Help Set the Rules of the Road

Consistent with recent FDA initiatives directed at leveraging AI technologies and improving early-phase clinical trial conduct, the FDA has issued a Request for Information (RFI) for input on a proposed AI-enabled optimization pilot program for early-phase clinical trials. The issues for which FDA is requesting information fall into two categories:  (A) Pilot program design and implementation and (B) Program evaluation metrics and success criteria.
...

Client Alert | 6 min read | 05.08.26

WISeR Under Scrutiny: AI Claims Review Debate Reaches CMS

The appropriate use of AI tools during the claims review process continues to be a major topic of debate within the health care industry — but in recent weeks, emerging litigation has inspired critics to turn their attention specifically to the technology’s application within federal health programs. On March 25, 2026, the Electronic Frontier Foundation (EFF) filed a lawsuit against the Centers for Medicare and Medicaid Services (CMS), citing the agency’s alleged failure to answer a Freedom of Information Act (FOIA) request for records the EFF believes will provide crucial insight into the design, safeguards, vendor relationships, and real-world performance of the Medicare Wasteful and Inappropriate Service Reduction (WISeR) Model, CMS’s  AI-driven prior authorization pilot program for certain Medicare services.
...

Client Alert | 4 min read | 05.06.26

Genetic Data and Artificial Intelligence Training Following Acquisitions: Emerging Litigation Risk and a Rapidly Expanding State Regulatory Landscape

Several recent class actions filed against Tempus AI, Inc., a health care technology company that combines AI with molecular and clinical data to develop precision medicine services, are the latest in a series of cases illustrating a fast-growing legal risk: the repurposing of genetic and clinical data — collected for diagnostic or treatment purposes — for artificial intelligence (AI) model training, analytics, and downstream commercialization following corporate acquisitions. At the same time, state genetic privacy regulation is expanding rapidly, with Utah and South Dakota being the most recent states to enact new statutes, and legislation advancing in several additional states. Organizations holding genetic datasets need to treat data governance as a core enterprise risk issue, not a downstream compliance matter.
...

Client Alert | 5 min read | 04.09.26

U.S. State Privacy Enforcement: Key Priorities and Practical Guidance From State Regulators

At the International Association of Privacy Professionals’ (IAPP) annual conference March 30-31, 2026, enforcement officials from California, Connecticut, Indiana, and Delaware shared their current and upcoming enforcement priorities under U.S. state consumer privacy laws. This alert summarizes the key themes from the panel and offers practical guidance for companies navigating the evolving enforcement landscape.
...

Client Alert | 5 min read | 04.07.26

Trump Administration Imposes Section 232 Tariffs on Patented Pharmaceutical Imports; Tiered Rate Structure Takes Effect Beginning July 31, 2026

On April 2, 2026, President Trump issued a Proclamation invoking Section 232 of the Trade Expansion Act of 1962, as amended (19 U.S.C. § 1862), to impose tariffs on imports of patented pharmaceuticals, biologics, and associated ingredients into the United States.  The action affects pharmaceutical manufacturers, importers, and supply chain participants.   
...

Client Alert | 4 min read | 04.02.26

FTC Announces New Health Care Task Force

In a development likely to ramp up regulatory pressure on an industry already under significant federal scrutiny, Federal Trade Commission (FTC) Chairman Andrew Ferguson recently directed leaders across his agency to launch a team dedicated to cooperatively advancing enforcement and advocacy activities relevant to health care.
...

Client Alert | 4 min read | 03.25.26

NAIC Intensifies AI Regulatory Focus: What Health Insurance Payors Need to Know

The National Association of Insurance Commissioners (NAIC) is intensifying its oversight of how insurers use AI — and the pace of regulatory activity shows no signs of slowing. Over the past several months, the NAIC has published a formal Issue Brief staking out its position on federal AI legislation, launched a multistate AI Evaluation Tool pilot aimed at examining insurers’ AI governance programs, and continued to expand adoption of its AI Model Bulletin across state lines. These developments continue a trend towards enhancing regulation; the NAIC adopted AI Principles in 2020 and a Model Bulletin in 2023 clarifying that existing insurance laws apply to AI systems and establishing expectations for governance, documentation, testing, and third-party oversight. That Model Bulletin has now been adopted in approximately 24 states.
...

Client Alert | 7 min read | 10.23.25

Ransomware on the Rise: The Expanding Role of Legal Counsel in Incident Response

Ransomware attacks continue to evolve in frequency, sophistication, and impact. Threat actors are now leveraging artificial intelligence to enhance phishing campaigns, automate data exfiltration, and execute double extortion schemes—where data is both encrypted and stolen for leverage.
...